Echo starts new study of noninvasive glucose monitor
This article was originally published in Clinica
Executive Summary
Echo Therapeutics has started another pilot study of its noninvasive wireless Symphony transdermal continuous glucose monitoring system (tCGM). Results from the study, in 10 type 1 and type 2 diabetes patients, are expected in the third quarter of 2008. The primary purpose of the trial is to evaluate the Symphony system with the Franklin, Massachusetts firm's new Prelude skin preparation system. It will compare data obtained using Symphony with the gold-standard YSI (Yellow Springs Instrument) Glucose Analyzer and a widely-used "finger stick" glucometer. Echo is developing Symphony for use both at home and in hospital. In March, it reported encouraging results from another pilot study (see Clinica No 1299, p 26). Other noninvasive glucose tests include OrSense's ring-like monitor, NBM-200G, and GlucoLight's Sentris-100.